AHR and chronic kidney disease: Therefore, pharmacological or dietary interventions that modulate AhR activity in the cellular circuitry to control intestinal peristalsis offer a realistic strategy for the management of conditions associated with gut dysmotility, including the constipation due to slow colonic transit common in patients with CKD.